By Francine Lane & Thomas Wicks
With 2018 not far behind us, we turn our attention to the coming year. On a daily basis, TrialScope’s collective fingers are on the pulse of clinical trial disclosure and transparency. Over the past decade and more, we have seen a heightened awareness of – and focus on – the compliance of clinical trial sponsors. And so we offer a laundry list of 2019 predictions for the pharmaceutical industry: